Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-21-015730
Filing Date
2021-11-18
Accepted
2021-11-18 21:56:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 50740
2 GRAPHIC g211954g1118175232486.jpg GRAPHIC 2403
  Complete submission text file 0000950123-21-015730.txt   55090
Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Filer) CIK: 0001880438 (see all company filings)

EIN.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations